New England Journal of Medicine Publishes eNRGy Trial Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer ...

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause of bacterial pneumonia for them. Indeed, it was the most frequently isolated ...

Given the evolving role of trastuzumab deruxtecan (Enhertu) in the treatment of breast cancer, especially those who are HER2 ...

Treatment with TNF inhibitors yielded no differences in outcomes vs. other antirheumatic therapies among U.S. veterans with ...

An oxygen saturation monitor has been bought for Glangwili Hospital. The monitor, which comes with an ear probe, was bought for the Interstitial Lung Disease (ILD) team at the hospital, thanks to ...

If you have a difficult time breathing or if you suffer from a dry and persistent cough, you may be suffering from ...

If you often have a difficult time breathing or if you suffer from a dry and persistent cough, you may be suffering from a ...

Watch this brave little girl deal with a very tough start to life after being diagnosed with an extremely rare lung disease. Jewel Hee from Colorado Springs, Colorado, USA, supported her daughter, ...

Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary ...

A Ceredigion village football club’s generous donation to Hywel Dda Health Charities, the official charity of Hywel Dda ...

I am once again making MannKind Corp. (MNKD) my "Top Pick" for more aggressive investors in 2025, advises Nate Pile, editor of Nate’s Notes.

摘要本文系统复习了自2023年10月至2024年9月期间、国内外权威杂志中间质性肺疾病诊疗相关的文献，重点关注特发性肺纤维化、结缔组织疾病相关性间质性肺疾病和结节病等疾病，内容上主要涉及上述疾病的发病机制、诊断和治疗进展以及其权威诊疗共识、指南。20 ...